New York Valves, CRF’s newest cardiology conference, makes heart team collaborations a priority

The Cardiovascular Research Foundation (CRF) has provided an updated look at its newest conference, New York Valves: The Structural Heart Summit.

New York Valves, scheduled for June 5-7, 2024, replaces the Transcatheter Valve Therapy (TVT) conference that CRF hosted for many years. It is expected to attract clinical cardiologists, interventional cardiologists, cardiac surgeons, imaging specialists and other key members of the heart team from all over the world.

One key difference between New York Valves and TVT is an increased focus on inclusivity and collaboration. Martin B. Leon, MD, CRF’s founder, highlighted this step forward in a preview of the new conference.

“This is an exciting evolution of what we’ve done in the past, taking us to a completely difference space in managing the lifelong journey of patients with valvular heart disease,” Leon, a veteran interventional cardiologist and professor of medicine at Columbia University Irving Medical Center, explained. “This meeting doesn’t just deal with transcatheter therapy, but introduces all of the imaging expertise that is needed. It’s a meeting for our surgical colleagues, who have a variety of new techniques and treatments we need to embrace. It brings in the clinical cardiologists that diagnose valvular heart disease and manages these patients and it really elevates the heart team as being the central focus for decision-making and patient care.”

Transcatheter aortic valve replacement (TAVR), structural heart disease, interventional cardiology and cardiac imaging are just some of the topics that will be explored during 12 late-breaking clinical trial presentations and six featured clinical science presentations.

In addition, researchers will present more than 100 abstracts with attendees.

Late-breaking clinical trials announced for New York Valves: The Structural Heart Summit

Wednesday, June 5: TAVR

11:00 a.m. — 12:00 p.m. ET

A Randomized Comparison of TAVR and SAVR in Low-Risk Patients Aged 70 Years or Younger: Results From the NOTION-2 Trial

Ole De Backer

Predictors of Bioprosthetic Valve Dysfunction From the Randomized SMART Trial

Howard C. Herrmann

Impact of Cerebral Embolic Protection Devices on Disabling Stroke After Transcatheter Aortic Valve Replacement: Results From the STS/ACC TVT Registry

Neel Butala

Late Clinical Outcomes With Balloon Expandable Valves in Small Annulus Patients From the PARTNER Trials

Rebecca T. Hahn

Thursday, June 6: Mitral and Tricuspid

11:00 a.m. — 12:00 p.m. ET

T-TEER in a Broad Range of Anatomies: Results From the TRILUMINATE Pivotal Trial

Brian K. Whisenant

Impact of Tricuspid Regurgitation on Right Heart Remodeling: Insights From the TRILUMINATE Pivotal MRI and CT Imaging Substudy

Joao L. Cavalcante

Surgical Mitral Valve Replacement With a Novel Polymeric Valve: 30-day Results From a Global Clinical Study of the Foldax TRIA Mitral Valve

Isaac George

Incidence, Predictors, and Management of Conduction Disturbances After Transcatheter Tricuspid Valve Replacement: The TRIPLACE Registry

Andrea Scotti

Friday, June 7: TAVR and Mitral 2

11:00 a.m. — 12:00 p.m. ET

Impact of Bioprosthetic Valve Performance on 5-year Clinical Outcomes in Patients at Intermediate or Greater Surgical Risk

Steven J. Yakubov

Evaluating Mitral TEER in the Management of Moderate Mitral Regurgitation Among Heart Failure Patients

Anita W. Asgar

Transcatheter Edge-to-Edge Repair vs Transcatheter Mitral Valve Replacement in Patients With Primary Mitral Regurgitation and Red Zone Anatomy: A Propensity Score-Matched Analysis

Sebastian Ludwig

Mid-term Outcomes of Balloon Expandable TAVR for the Treatment of Failed Bioprosthetic Valves in the United States

Tsuyoshi Kaneko

Click here for additional details from CRF about New York Valves: The Structural Heart Summit.

Michael Walter
Michael Walter, Managing Editor

Michael has more than 16 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.

Around the web

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."

Philips introduced a new CT system at ECR aimed at the rapidly growing cardiac CT market, incorporating numerous AI features to optimize workflow and image quality.

Trimed Popup
Trimed Popup